Nick Glover
2017
In 2017, Nick Glover earned a total compensation of $1.1M as President and Chief Executive Officer at ProNAi Therapeutics, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $330,750 |
|---|---|
| Option Awards | $215,056 |
| Salary | $551,250 |
| Other | $19,247 |
| Total | $1,116,303 |
Glover received $551.3K in salary, accounting for 49% of the total pay in 2017.
Glover also received $330.8K in non-equity incentive plan, $215.1K in option awards and $19.2K in other compensation.
Rankings
In 2017, Nick Glover's compensation ranked 8,456th out of 14,666 executives tracked by ExecPay. In other words, Glover earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,456 out of 14,666 | 42nd |
Division Manufacturing | 3,204 out of 5,772 | 45th |
Major group Chemicals And Allied Products | 1,064 out of 2,075 | 49th |
Industry group Drugs | 840 out of 1,731 | 52nd |
Industry Pharmaceutical Preparations | 657 out of 1,333 | 51st |
Source: SEC filing on April 24, 2018.
Glover's colleagues
We found two more compensation records of executives who worked with Nick Glover at ProNAi Therapeutics in 2017.